Literature DB >> 22703924

Extraosseous Ewing sarcoma with foci of neuroblastoma-like differentiation associated with EWSR1(Ewing sarcoma breakpoint region 1)/FLI1 translocation without prior chemotherapy.

K Vali1, V Kokta, M Beaunoyer, R Fetni, P Teira, Hervé Sartelet.   

Abstract

Peripheral primitive neuroectodermal tumor/Ewing sarcoma and neuroblastoma are distinct malignant tumors belonging to the group of undifferentiated solid pediatric tumors. We report a case of a 14-year-old adolescent girl who presented with a right lower quadrant mass. At surgery, a mobile retroperitoneal mass was entirely removed. Histologic evaluation revealed 2 distinct components; the first, consisting of sheets of undifferentiated cells, was CD99+ and CD56-, whereas the second, consisting of multiple foci of neuropil and maturing neuroblasts, was CD99- and CD56+. Fluorescence in situ hybridization analysis revealed the presence of EWSR1/FLI1 translocation in both histologic distinct components. MYCN (myelocytomatosis viral related oncogene, neuroblastoma derived) was not amplified. The tests for t(11;22) and t(21;22) performed by reverse transcription-polymerase chain reaction were negative. The final diagnosis corresponds to an extraosseous Ewing sarcoma with foci of neuroblastoma-like differentiation. This is the first case, documented by molecular studies, in which neuroblastoma-like differentiation has been noted in primitive neuroectodermal tumor/Ewing sarcoma without prior chemotherapy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22703924     DOI: 10.1016/j.humpath.2012.03.006

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  2 in total

1.  Atypical growth on MRI in a case of Ewing's sarcoma despite lower SUV on PET.

Authors:  Zachary Sanford; Stanford Israelsen; Rajesh Sehgal; Felix H Cheung
Journal:  Skeletal Radiol       Date:  2013-12-19       Impact factor: 2.199

2.  Cervical ganglioneuroma in collision with a metastatic undifferentiated carcinoma.

Authors:  Mark N Jabbour; Ghazi S Zaatari; Ziad Salem; Ibrahim Khalifeh
Journal:  J Oral Maxillofac Pathol       Date:  2015 Jan-Apr
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.